Zobrazeno 1 - 8
of 8
pro vyhledávání: '"LRR Castello-Branco"'
Publikováno v:
Memorias do Instituto Oswaldo Cruz, Vol 93, Iss 3, Pp 387-390 (1998)
Patients with secondary immunodeficiencies are at a high risk of infection. Currently some of these infections are preventable through specific immunization. Prevention of these diseases can diminish morbidity and mortality amongst these patients. In
Externí odkaz:
https://doaj.org/article/a1a61f50503e43cbb096a7e803272404
Publikováno v:
Memorias do Instituto Oswaldo Cruz, Vol 91, Iss 3, Pp 363-366 (1996)
The gut associated lymphoid tissue is responsible for specific responses to intestinal antigens. During HIV infection, mucosal immune deficiency may account for the gastrointestinal infections. In this review we describe the humoral and cellular muco
Externí odkaz:
https://doaj.org/article/47ac09747e9d493799450cc16249929a
Publikováno v:
Memorias do Instituto Oswaldo Cruz, Vol 91, Iss 3, Pp 367-369 (1996)
The mucosa associated lymphoid tissue regulates and coordinates immune responses against mucosal pathogens. Mucosal tissues are the major targets exposed to HIV during transmission. In this paper we describe in vitro models of HIV mucosal infection u
Externí odkaz:
https://doaj.org/article/3c86d2c423514f94a128fd928c556a58
Autor:
M. B. Ortigao-De-Sampaio, Lrr Castello-Branco, A Ponce de Leon, TF Abreu, M. I. Linhares-De-Carvalho
Publikováno v:
Journal of Tropical Pediatrics. 45:299-301
In order to test the predictive value of immune complex-dissociated p24 antigenaemia (ICD-p24Ag), beta 2 microglobulin (beta 2-M), and neopterin as markers of disease progression, 53 HIV-1 infected children (mean age 68 months) and nine HIV-negative
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d3fa5bf4795fbdd99cdc6c681f3f3e6c
https://doi.org/10.1093/tropej/45.5.299
https://doi.org/10.1093/tropej/45.5.299
Publikováno v:
Clinical Science. 84:6P-7P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b304c7c993256de3df17c5cee569091
https://doi.org/10.1042/cs084006pc
https://doi.org/10.1042/cs084006pc
Autor:
Antas PRZ; Laboratório de Imunologia Clínica, Instituto Oswaldo Cruz, Fiocruz, and Instituto Nacional de Ciência e Tecnologia em Tuberculose (INCT-TB), Rio de Janeiro 21040-900, Brazil., da Silva ASM; Laboratório de Imunologia Clínica, Instituto Oswaldo Cruz, Fiocruz, and Instituto Nacional de Ciência e Tecnologia em Tuberculose (INCT-TB), Rio de Janeiro 21040-900, Brazil., Albuquerque LHP; Laboratório de Imunologia Clínica, Instituto Oswaldo Cruz, Fiocruz, and Instituto Nacional de Ciência e Tecnologia em Tuberculose (INCT-TB), Rio de Janeiro 21040-900, Brazil., Almeida MR; Laboratório de Imunologia Clínica, Instituto Oswaldo Cruz, Fiocruz, and Instituto Nacional de Ciência e Tecnologia em Tuberculose (INCT-TB), Rio de Janeiro 21040-900, Brazil.; Department of Infectious Diseases, Leiden University Medical Centre, 2333ZA Leiden, The Netherlands., Pereira ENGS; Laboratório de Investigação Cardiovascular, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-900, Brazil., Castello-Branco LRR; Laboratório de Imunologia Clínica, Instituto Oswaldo Cruz, Fiocruz, and Instituto Nacional de Ciência e Tecnologia em Tuberculose (INCT-TB), Rio de Janeiro 21040-900, Brazil., de Ponte CGG; Laboratório de Imunologia Clínica, Instituto Oswaldo Cruz, Fiocruz, and Instituto Nacional de Ciência e Tecnologia em Tuberculose (INCT-TB), Rio de Janeiro 21040-900, Brazil.
Publikováno v:
Vaccines [Vaccines (Basel)] 2022 Dec 30; Vol. 11 (1). Date of Electronic Publication: 2022 Dec 30.
Autor:
Castello-Branco LRR; Fundação Ataulpho de Paiva, Rio de Janeiro, RJ, Brasil.
Publikováno v:
International braz j urol : official journal of the Brazilian Society of Urology [Int Braz J Urol] 2021 May-Jun; Vol. 47 (3), pp. 482-483.
Autor:
Antas PRZ; 1Laboratório de Imunologia Clínica, Oswaldo Cruz Institute, Fiocruz, Pavilhao Leonidas Deane, 4th Floor, Av. Brasil 4365, Rio de Janeiro, RJ 21045-900 Brazil., Ponte CGG; 1Laboratório de Imunologia Clínica, Oswaldo Cruz Institute, Fiocruz, Pavilhao Leonidas Deane, 4th Floor, Av. Brasil 4365, Rio de Janeiro, RJ 21045-900 Brazil., Almeida MR; 1Laboratório de Imunologia Clínica, Oswaldo Cruz Institute, Fiocruz, Pavilhao Leonidas Deane, 4th Floor, Av. Brasil 4365, Rio de Janeiro, RJ 21045-900 Brazil., Albuquerque LHP; 1Laboratório de Imunologia Clínica, Oswaldo Cruz Institute, Fiocruz, Pavilhao Leonidas Deane, 4th Floor, Av. Brasil 4365, Rio de Janeiro, RJ 21045-900 Brazil., Sousa-Vasconcelos PS; 1Laboratório de Imunologia Clínica, Oswaldo Cruz Institute, Fiocruz, Pavilhao Leonidas Deane, 4th Floor, Av. Brasil 4365, Rio de Janeiro, RJ 21045-900 Brazil., Pedro T; 1Laboratório de Imunologia Clínica, Oswaldo Cruz Institute, Fiocruz, Pavilhao Leonidas Deane, 4th Floor, Av. Brasil 4365, Rio de Janeiro, RJ 21045-900 Brazil., Gomes NLS; 2Laboratório de Biologia Molecular e Doenças Endêmicas, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, Brazil., Moreira OC; 2Laboratório de Biologia Molecular e Doenças Endêmicas, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, Brazil., Silva FC; Gaffree Guinle State University Hospital of Rio de Janeiro, Rio de Janeiro, Brazil., Castello-Branco LRR; 1Laboratório de Imunologia Clínica, Oswaldo Cruz Institute, Fiocruz, Pavilhao Leonidas Deane, 4th Floor, Av. Brasil 4365, Rio de Janeiro, RJ 21045-900 Brazil., Pinho RT; 1Laboratório de Imunologia Clínica, Oswaldo Cruz Institute, Fiocruz, Pavilhao Leonidas Deane, 4th Floor, Av. Brasil 4365, Rio de Janeiro, RJ 21045-900 Brazil.
Publikováno v:
Journal of inflammation (London, England) [J Inflamm (Lond)] 2019 Jul 15; Vol. 16, pp. 18. Date of Electronic Publication: 2019 Jul 15 (Print Publication: 2019).